Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 24203647)

Published in Chemistry on November 07, 2013

Authors

Michael I Webb1, Boris Wu, Thalia Jang, Ryan A Chard, Edwin W Y Wong, May Q Wong, Donald T T Yapp, Charles J Walsby

Author Affiliations

1: Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6 (Canada), Fax: (+1) 778-782-3765.

Articles by these authors

Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS One (2008) 1.93

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One (2008) 1.14

Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. Clin Cancer Res (2008) 0.99

Comparison of bifunctional chelates for (64)Cu antibody imaging. Eur J Nucl Med Mol Imaging (2010) 0.98

How an enzyme tames reactive intermediates: positioning of the active-site components of lysine 2,3-aminomutase during enzymatic turnover as determined by ENDOR spectroscopy. J Am Chem Soc (2006) 0.96

RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Nucl Med Biol (2012) 0.89

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization. Mol Cancer Res (2004) 0.89

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin. Breast Cancer Res Treat (2007) 0.87

Dual mode fluorescent (18)F-PET tracers: efficient modular synthesis of rhodamine-[cRGD]2-[(18)F]-organotrifluoroborate, rapid, and high yielding one-step (18)F-labeling at high specific activity, and correlated in vivo PET imaging and ex vivo fluorescence. Bioconjug Chem (2014) 0.87

Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging. Nucl Med Biol (2013) 0.85

(68)Ga small peptide imaging: comparison of NOTA and PCTA. Bioconjug Chem (2012) 0.83

Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR. J Biol Inorg Chem (2009) 0.81

Direct observation of activated hydrogen binding to a supported organometallic compound at room temperature. Chemistry (2012) 0.81

Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice. Nucl Med Biol (2013) 0.80

Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. Bioorg Med Chem (2012) 0.80

Assessment of vessel size by MRI in an orthotopic model of human pancreatic cancer. Conf Proc IEEE Eng Med Biol Soc (2008) 0.78

Gold(II) phthalocyanine revisited: synthesis and spectroscopic properties of gold(III) phthalocyanine and an unprecedented ring-contracted phthalocyanine analogue. Chemistry (2012) 0.77

Pyridine analogues of the antimetastatic Ru(III) complex NAMI-A targeting non-covalent interactions with albumin. Inorg Chem (2011) 0.77

Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin. Dalton Trans (2011) 0.77

Non-innocent ligand behavior of a bimetallic Ni Schiff-base complex containing a bridging catecholate. Inorg Chem (2011) 0.77

Isotope effects for deuterium transfer and mutagenesis of Tyr187 provide insight into controlled radical chemistry in adenosylcobalamin-dependent ornithine 4,5-aminomutase. Biochemistry (2014) 0.76

Carbon-centered strong bases in phosphonium ionic liquids. J Org Chem (2008) 0.76

Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages. Radiat Res (2004) 0.76

EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds. Metallomics (2013) 0.76

Albumin binding and ligand-exchange processes of the Ru(iii) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy. Dalton Trans (2015) 0.76

Imaging tumor vasculature noninvasively with positron emission tomography and RGD peptides labeled with copper 64 using the bifunctonal chelates DOTA, oxo-DO3a. and PCTA. Mol Imaging (2013) 0.75

Phthalocyanine as a chemically inert, redox-active ligand: structural and electronic properties of a Nb(IV)-oxo complex incorporating a highly reduced phthalocyanine(4-) anion. Inorg Chem (2010) 0.75

Synthesis, characterization, and biological studies of emissive rhenium-glutamine conjugates. J Biol Inorg Chem (2013) 0.75

Design and synthesis of vanadium hydrazide gels for Kubas-type hydrogen adsorption: a new class of hydrogen storage materials. J Am Chem Soc (2010) 0.75

Induction of Cytotoxicity in Pyridine Analogues of the Anti-metastatic Ru(III) Complex NAMI-A by Ferrocene Functionalization. Inorg Chem (2015) 0.75

Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity. Metallomics (2014) 0.75

A mild Pummerer-like reaction of carbohydrate-based selenoethers and thioethers involving linear ozonide acetates as putative intermediates. J Am Chem Soc (2006) 0.75

Synthesis, characterization and catalytic activity of copper(II) complexes containing a redox-active benzoxazole iminosemiquinone ligand. Dalton Trans (2013) 0.75

Grignard reagents in ionic solvents: electron transfer reactions and evidence for facile Br-Mg exchange. Chem Commun (Camb) (2007) 0.75